Fighting S. aureus catheter-related infections with sophorolipids: Electing an antiadhesive strategy or a release one?
- PMID: 34464911
- DOI: 10.1016/j.colsurfb.2021.112057
Fighting S. aureus catheter-related infections with sophorolipids: Electing an antiadhesive strategy or a release one?
Abstract
Staphylococcus aureus medical devices related-infections, such as blood stream catheter are of major concern. Their prevention is compulsory and strategies, not prone to the development of resistance, to prevent S. aureus biofilms on catheter surfaces (e.g. silicone) are needed. In this work two different approaches using sophorolipids were studied to prevent S. aureus biofilm formation on medical grade silicone: i) an antiadhesive strategy through covalent bond of sophorolipids to the surface; ii) and a release strategy using isolated most active sophorolipids. Sophorolipids produced by Starmerella bombicola, were characterized by UHPLC-MS and RMN, purified by automatic flash chromatography and tested for their antimicrobial activity towards S. aureus. Highest antimicrobial activity was observed for C18:0 and C18:1 diacetylated lactonic sophorolipids showing a MIC of 50 μg mL-1. Surface modification with acidic or lactonic sophorolipids when evaluating the anti-adhesive or release strategy, respectively, was confirmed by contact angle, FTIR-ATR and AFM analysis. When using a mixture of acidic sophorolipids covalently bonded to silicone surface as antiadhesive strategy cytocompatible surfaces were obtained and a reduction of 90 % on biofilm formation was observed. Nevertheless, if a release strategy is adopted with purified lactonic sophorolipids a higher effect is achieved. Most promising compound was C18:1 diacateylated lactonic sophorolipid that showed no cellular viability reduction when a concentration of 1.5 mg mL-1 was selected and a reduction on biofilm around 5 log units. Results reinforce the applicability of these antimicrobial biosurfactants on preventing biofilms and disclose that their antimicrobial effect is imperative when comparing to their antiadhesive properties.
Keywords: Anti-adhesive; Antibacterial surface; Biofilm; Release; S. aureus; Self-assembling monolayers.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
The effect of sophorolipids against microbial biofilms on medical-grade silicone.J Biotechnol. 2020 Feb 10;309:34-43. doi: 10.1016/j.jbiotec.2019.12.019. Epub 2019 Dec 27. J Biotechnol. 2020. PMID: 31887325
-
Production of new antimicrobial palm oil-derived sophorolipids by the yeast Starmerella riodocensis sp. nov. against Candida albicans hyphal and biofilm formation.Microb Cell Fact. 2022 Aug 17;21(1):163. doi: 10.1186/s12934-022-01852-y. Microb Cell Fact. 2022. PMID: 35974372 Free PMC article.
-
Can Sophorolipids prevent biofilm formation on silicone catheter tubes?Int J Pharm. 2016 Nov 20;513(1-2):697-708. doi: 10.1016/j.ijpharm.2016.09.074. Epub 2016 Sep 28. Int J Pharm. 2016. PMID: 27693709
-
Sophorolipids bioproduction in the yeast Starmerella bombicola: Current trends and perspectives.Bioresour Technol. 2022 Feb;346:126593. doi: 10.1016/j.biortech.2021.126593. Epub 2021 Dec 20. Bioresour Technol. 2022. PMID: 34942344 Review.
-
Biological activity of sophorolipids and their possible use as antiviral agents.Folia Microbiol (Praha). 2016 Jan;61(1):85-9. doi: 10.1007/s12223-015-0413-z. Epub 2015 Jul 1. Folia Microbiol (Praha). 2016. PMID: 26126789 Review.
Cited by
-
Exploring the biofilm inhibitory potential of Candida sp. UFSJ7A glycolipid on siliconized latex catheters.Braz J Microbiol. 2024 Sep;55(3):2119-2130. doi: 10.1007/s42770-024-01431-w. Epub 2024 Jul 2. Braz J Microbiol. 2024. PMID: 38954220
-
Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19.Bioengineered. 2021 Dec;12(2):9550-9560. doi: 10.1080/21655979.2021.1997261. Bioengineered. 2021. PMID: 34709115 Free PMC article. Review.
-
Valorization of oil refinery by-products: production of sophorolipids utilizing fatty acid distillates and their potential antibacterial, anti-biofilm, and antifungal activities.World J Microbiol Biotechnol. 2024 Oct 10;40(11):344. doi: 10.1007/s11274-024-04144-2. World J Microbiol Biotechnol. 2024. PMID: 39384621
-
Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by Candida Biofilm Formation.Pathogens. 2021 Oct 23;10(11):1371. doi: 10.3390/pathogens10111371. Pathogens. 2021. PMID: 34832527 Free PMC article.
-
Candida krusei M4CK Produces a Bioemulsifier That Acts on Melaleuca Essential Oil and Aids in Its Antibacterial and Antibiofilm Activity.Antibiotics (Basel). 2023 Nov 30;12(12):1686. doi: 10.3390/antibiotics12121686. Antibiotics (Basel). 2023. PMID: 38136720 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous